| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $228.4M | -2.1% |
| Cost of Revenue | $128.8M | -3.9% |
| Gross Profit | $99.6M | +0.3% |
| R&D Expense | $17.7M | -1.8% |
| SG&A Expense | $149.0M | +1.4% |
| Operating Income | -$130.9M | -13.6% |
| Pre-tax Income | -$113.5M | -14.2% |
| Income Tax | $1.3M | +433.9% |
| Net Income | -$114.8M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $45.3M | -2.3% |
| Short-term Investments | $216.5M | -47.3% |
| Accounts Receivable | $45.8M | +8.8% |
| Inventory | $22.5M | -14.3% |
| Current Assets | $341.6M | -36.2% |
| Total Assets | $703.5M | -26.5% |
| Current Liabilities | $64.6M | +41.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$16.3M | -2056.3% |
| Capital Expenditures | $17.3M | -55.5% |
| Investing Cash Flow | $176.8M | +390.5% |
| Financing Cash Flow | -$161.5M | -578.8% |
| Free Cash Flow | -$33.6M | +15.1% |
| -15.2% |
| EPS (Basic) | -$2.49 | -12.7% |
| EPS (Diluted) | -$2.49 | -12.7% |
| Total Liabilities |
| $301.6M |
| -35.7% |
| Stockholders' Equity | $401.9M | -17.8% |